Skip to main content
. 2017 Apr 24;177(6):774–783. doi: 10.1001/jamainternmed.2017.0895

Figure 3. Time to Cytomegalovirus (CMV) Viral Reactivation in Blood.

Figure 3.

A, Time to CMV viral reactivation in blood in combined treatment groups (valacyclovir and valganciclovir arms) vs control group (hazard ratio, 0.14; 95% CI, 0.04-0.50). B, Time to CMV viral reactivation in blood in valganciclovir group vs control group (hazard ratio, 0.08; 95% CI, 0.01-0.58).